OncoCyte Historical Cash Flow
| OCX Stock | USD 3.18 0.14 4.61% |
Analysis of OncoCyte Corp cash flow over time is an excellent tool to project OncoCyte Corp future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 1.6 M or Other Non Cash Items of 38.5 M as it is a great indicator of OncoCyte Corp ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining OncoCyte Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether OncoCyte Corp is a good buy for the upcoming year.
OncoCyte |
About OncoCyte Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in OncoCyte balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which OncoCyte's non-liquid assets can be easily converted into cash.
OncoCyte Corp Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by OncoCyte Corp to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of OncoCyte Corp operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from OncoCyte Corp's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into OncoCyte Corp current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OncoCyte Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy OncoCyte Stock please use our How to Invest in OncoCyte Corp guide.At this time, OncoCyte Corp's Dividends Paid is fairly stable compared to the past year.
OncoCyte Corp cash flow statement Correlations
Click cells to compare fundamentals
OncoCyte Corp Account Relationship Matchups
High Positive Relationship
High Negative Relationship
OncoCyte Corp cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | (14.9M) | 28.5M | (14.1M) | (12.1M) | (796K) | (756.2K) | |
| Stock Based Compensation | 5.1M | 6.8M | 10.0M | 6.6M | 1.8M | 1.7M | |
| Free Cash Flow | (27.2M) | (38.2M) | (49.9M) | (23.6M) | (20.7M) | (21.7M) | |
| Change In Working Capital | 399K | (2.2M) | (1.9M) | (4.0M) | (1.3M) | (1.3M) | |
| Begin Period Cash Flow | 23.8M | 8.8M | 37.3M | 23.2M | 11.1M | 12.8M | |
| Other Cashflows From Financing Activities | 5.0M | 7.4M | 4.4M | (1.5M) | 20.4M | 21.5M | |
| Depreciation | 1.9M | 4.2M | 5.2M | 1.7M | 1.6M | 1.6M | |
| Other Non Cash Items | (2.2M) | 28.6M | 14.0M | 174K | 36.6M | 38.5M | |
| Capital Expenditures | 1.2M | 2.2M | 4.3M | 281K | 516K | 943.3K | |
| Total Cash From Operating Activities | (26.0M) | (35.9M) | (45.6M) | (23.3M) | (20.7M) | (21.7M) | |
| Net Income | (29.9M) | (64.1M) | (72.9M) | (27.8M) | (60.7M) | (57.6M) | |
| End Period Cash Flow | 8.8M | 37.3M | 23.2M | 11.1M | 10.3M | 13.6M | |
| Change To Liabilities | (1.4M) | 854K | (1.3M) | 297K | 267.3K | 280.7K | |
| Sale Purchase Of Stock | (14K) | (239K) | 32.4M | (1.1M) | (5.4M) | (5.1M) | |
| Investments | (4M) | (14.0M) | (4.3M) | (932K) | (512K) | (537.6K) | |
| Net Borrowings | 2.3M | 695K | (1.5M) | (1.3M) | (1.2M) | (1.1M) | |
| Total Cashflows From Investing Activities | (12.4M) | (11.7M) | (14.0M) | (4.3M) | (3.9M) | (4.1M) | |
| Change To Operating Activities | (9K) | (2.3M) | (273K) | 2.7M | 2.5M | 2.6M | |
| Total Cash From Financing Activities | 22.8M | 78.4M | 35.8M | 12.2M | 20.4M | 27.3M | |
| Other Cashflows From Investing Activities | (332K) | (11.7M) | (4.3M) | (1.0M) | (512K) | (537.6K) | |
| Change To Netincome | 3.8M | 1.5M | 23.7M | 24.0M | 27.7M | 29.0M | |
| Cash And Cash Equivalents Changes | 15.7M | (14.9M) | 28.5M | (14.1M) | (12.7M) | (12.1M) | |
| Cash Flows Other Operating | (158K) | 1.3M | 2.7M | (1.7M) | (1.5M) | (1.4M) | |
| Issuance Of Capital Stock | 20.8M | 78.0M | 37.7M | 13.8M | 27.8M | 27.5M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for OncoCyte Stock Analysis
When running OncoCyte Corp's price analysis, check to measure OncoCyte Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OncoCyte Corp is operating at the current time. Most of OncoCyte Corp's value examination focuses on studying past and present price action to predict the probability of OncoCyte Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OncoCyte Corp's price. Additionally, you may evaluate how the addition of OncoCyte Corp to your portfolios can decrease your overall portfolio volatility.